Status:
TERMINATED
Comparison of Pulsed-field Gel Electrophoresis and Whole Genome Sequencing to Determine Transmission Rate of ESBL-producing E.Coli
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Analysis Transmission Rate
Eligibility:
All Genders
Brief Summary
The aim of this quality control study is to compare two different techniques to determine ESBL-producing E.coli transmission.
Detailed Description
Pulse-field gel electrophoresis (PFGE) was considered the reference standard to determine transmission events of extended-spectrum Beta-Lactamase (ESBL) producing E.coli . However, this technique lack...
Eligibility Criteria
Inclusion
- The patient population is defined as the 24 contact-index patient pairs identified during screening of contact patients after cessation of contact precautions as part of a quality control, performed from June 2012 to December 2013 at the University Hospital Basel and from January 2012 to December 2013 at the FELIX PLATTER-Hospital.
Exclusion
- Patients not meeting the above mentioned inclusion criteria.
Key Trial Info
Start Date :
March 6 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 7 2025
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT04323553
Start Date
March 6 2020
End Date
January 7 2025
Last Update
January 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Basel, Division of Infectious Diseases and Hospital Epidemiology
Basel, Switzerland, 4031